Xtenda

Xtenda

ceftriaxone

Manufacturer:

Samchundang Pharm

Distributor:

PHARMASIA
Concise Prescribing Info
Contents
Ceftriaxone Na
Indications/Uses
Lower resp tract infections, acute bacterial otitis media, skin & skin structure infections, UTI, uncomplicated gonorrhea, pelvic inflammatory disease, bacterial septicemia, bone & joint infections, intra-abdominal infections, meningitis, surgical prophylaxis.
Dosage/Direction for Use
Adult 1-2 g once a day or in equally divided doses bid, depending on type & severity of infection. Total daily dose should not exceed 4 g. Surgical prophylaxis 1 g IV ½-2 hr pre-op. Gonorrhea 250 mg IM as single dose. Childn Skin & skin structure infection 50-75 mg/kg/day, total daily dose should not exceed 2 g. Acute bacterial otitis media 50 mg/kg IM as single dose, not to exceed 1 g. Other serious infections 50-75 mg/kg/day given in divided doses 12 hrly. Max total daily dose: 2 g/day. Meningitis Initially 100 mg/kg/day (not to exceed 4 g/day). Daily dose may be administered once daily or in equally divided doses 12 hrly for 7-14 days.
Contraindications
Hypersensitivity to cephalosporin.
Special Precautions
Prolonged use may result in an overgrowth of nonsusceptible organism. History of GI disease especially colitis. Penicillin-sensitive patients. Pseudomembranous colitis. Patient w/ hepatic dysfunction & renal disease. Monitor prothrombin time in patients w/ impaired vit K synthesis or low vit K stores (eg, chronic hepatic disease & malnutrition). Pregnancy & lactation. Do not administer to hyperbilirubinemic neonates especially premature. Infant & childn. Elderly.
Adverse Reactions
Pain, induration, tenderness & inj site reaction after IM administration. Rash; thrombocytosis, leukopenia; diarrhea, elevations of SGOT, SGPT & BUN. Headache or dizziness; moniliasis or vaginitis; diaphoresis & flushing.
Drug Interactions
Decreased serum clearance w/ higher doses of probenecid. May be additive or synergistic effects w/ aminoglycosides (eg, amikacin, gentamicin, tobramycin). Synergistic effects w/ quinolones. Enhanced disulfiram-like effects w/ alcohol.
MIMS Class
ATC Classification
J01DD04 - ceftriaxone ; Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
Presentation/Packing
Form
Xtenda powd for inj 1 g
Packing/Price
1's (P1,155/vial)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in